Radiopharm Theranostics reports 93% trial success
Radiopharm Theranostics (ASX:RAD) reported positive Phase 2b trial results for RAD 101, showing 93% image concordance in brain metastasis patients.
Radiopharm Theranostics (ASX:RAD) reported positive Phase 2b trial results for RAD 101, showing 93% image concordance in brain metastasis patients.
Telegram said it will launch a native self-custody Gram (CRYPTO:GRAM) wallet this summer.
Beetaloo Energy (ASX:BTL) secured exclusive land rights near Darwin for a proposed $40 billion data centre and energy project.
Bitcoin (CRYPTO:BTC) rose above US$66,000 after reports that the White House accepted ethics changes to the CLARITY Act.
Westgold Resources (ASX:WGX) produced 387,354 ounces of gold in FY26 to surpass its annual guidance range.
Mercury NZ (ASX:MCY) generated NZ$390 million in fourth-quarter trading margin, representing a 33% growth a year earlier.
Outdoor retail group KMD Brands (ASX:KMD) expects full-year group sales to reach up to NZ$1.44 billion for the 2026 financial year.
Australia Post has secured $40.5 million in federal funding to accelerate the rollout of its heavy electric vehicle fleet.
Data centre provider Iren (NASDAQ:IREN) has secured US$2.8 billion in new cloud service agreements.
KIDZ AI (NASDAQ:KIDZ) signed a 60-month, $44.6 million GPU compute agreement with Canopy Wave for enterprise AI inference workloads.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas